SEC Contract Filing

Filing Date: 2022-09-13

Document Content:
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>13
<FILENAME>ex_422223.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<html><head>
	<title>ex_422223.htm</title>

	<!-- Generated by ThunderDome Portal - 9/11/2022 4:47:04 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.5</b></font></p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>Form of Participant Voting Commitment</u></b></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">DATE: September 9, 2022</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">TO:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Holders who entered into Reprice Letter Agreements with NovaBay Pharmaceuticals, Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">To Whom It May Concern:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Reference is made to that certain Letter Agreement, dated as of September 9, 2022 (the &#8220;<u>Letter Agreement</u>&#8221;), between the undersigned and NovaBay Pharmaceuticals, Inc. (the &#8220;<u>Company</u>&#8221;), which provides for the execution and delivery of this voting letter (&#8220;<u>Voting Letter</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">By signing this Voting Letter, the undersigned confirms and agrees that it shall vote all shares of the Company&#8217;s common stock, par value $0.01 per share (&#8220;<u>Common Stock</u>&#8221;), over which the undersigned has voting control in favor of any and all proposals and/or resolutions presented by the Company at any meeting of its stockholders to approve (i) a reverse stock split of the Common Stock (referred to as the &#8220;Stockholder Approval&#8221; in the Letter Agreement) and (ii) additional proposals that may be required by the rules of the NYSE American (referred to as the &#8220;Additional Stockholder Approvals&#8221; in the Letter Agreement). The undersigned understands that the Company intends to hold a special meeting of stockholders as soon as practicable and that the Board of Directors of the Company has established a record date of September 13, 2022 for this special meeting (the &#8220;<u>Record Date</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This commitment and agreement is being given by the undersigned in consideration of, and pursuant to its Letter Agreement, and is not revocable by the undersigned.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Voting Letter is intended for the exclusive benefit of the Company and its respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person, including without limitation any Other Holder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%; margin-left: 0pt; margin-right: 0pt;">

 <tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
 <td style="width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td>
 <td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">By:</td>
 <td colspan="2" style="width: 14%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
 </tr>
 <tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
 <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 50%;">&nbsp;</td>
 <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 2%;">&nbsp;</td>
 <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; wi